First Time Loading...

Adaptimmune Therapeutics PLC
NASDAQ:ADAP

Watchlist Manager
Adaptimmune Therapeutics PLC Logo
Adaptimmune Therapeutics PLC
NASDAQ:ADAP
Watchlist
Price: 1.075 USD 1.42% Market Closed
Updated: Apr 29, 2024

Adaptimmune Therapeutics PLC
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Adaptimmune Therapeutics PLC
Cash from Investing Activities Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Adaptimmune Therapeutics PLC
NASDAQ:ADAP
Cash from Investing Activities
$176.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Cash from Investing Activities
-$127m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Cash from Investing Activities
-$11m
CAGR 3-Years
9%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Cash from Investing Activities
-$2.9m
CAGR 3-Years
-35%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Cash from Investing Activities
-£5.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Cash from Investing Activities
-£21.4m
CAGR 3-Years
11%
CAGR 5-Years
15%
CAGR 10-Years
6%

See Also

What is Adaptimmune Therapeutics PLC's Cash from Investing Activities?
Cash from Investing Activities
176.5m USD

Based on the financial report for Dec 31, 2023, Adaptimmune Therapeutics PLC's Cash from Investing Activities amounts to 176.5m USD.

What is Adaptimmune Therapeutics PLC's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 1Y
98%

Over the last year, the Cash from Investing Activities growth was 98%.